New insights in pediculosis and scabies

Expert Review of Dermatology

Volumn 4, Issue 3, 2009, Pages 285-302

  Mumcuoglu, Kosta Y ^a   Gilead, Leon ^b   Ingber, Arieh ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Pediculus humanus capitis; Pediculus humanus humanus; Pthirus pubis; Sarcoptes scabiei

Indexed keywords

BENZYL BENZOATE; CITRONELLAL; CROTAMITON; IVERMECTIN; LINDANE; MALATHION; MYRISTIC ACID ISOPROPYL ESTER; PERMETHRIN; PLACEBO; PYRETHROID; SILICON DERIVATIVE; SULFUR;

APLASTIC ANEMIA; APPLICATION SITE IRRITATION; ARCHEOLOGY; CLINICAL FEATURE; CLINICAL TRIAL; CONVERGENT EVOLUTION; DEVICE THERAPY; DRUG MECHANISM; HEALTH EDUCATION; HUMAN; INFECTION PREVENTION; INFESTATION; INFLAMMATION; INSECTICIDE RESISTANCE; LEUKEMIA; NIT; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PEDICULOSIS; PEDICULOSIS CAPITIS; PEDICULUS; PERSONAL HYGIENE; PHYSICAL EXAMINATION; POLICY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUBIC PEDICULOSIS; RASH; REVIEW; SCABIES; TREATMENT CONTRAINDICATION; UNSPECIFIED SIDE EFFECT;

EID: 69949111943     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/edm.09.18     Document Type: Review

References (143)

1. Gratz N. Human lice, their prevalence and resistance to insecticides. WHO, Geneva, Switzerland (1998).
2. Taplin D, Meinking TL. Pyrethrins and pyrethroids for the treatment of scabies and pediculosis. Semin. Dermatol. 6, 125-135 (1987).
3. Hengge UR, Currie BJ, Jäger G, Lupi O, Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect. Dis. 6, 769-779 (2006).
4. Mumcuoglu KY, Miller J. The efficacy of pediculicides in Israel. Isr. J. Med. Sci. 27, 562-565 (1991).
5. Clore ER, Longyear LA. A comparative study of seven pediculicides and their packaged nit removal combs. J. Ped. Health Care 7, 55-60 (1993).
6. Meinking TL, Entzel P, Villar ME et al. Comparative efficacy of treatments for pediculosis capitis infestations: update 2000. Arch. Dermatol. 137, 287-292 (2001).
7. Meinking TL. Infestations. Curr. Probl. Dermatol. 11, 73-120 (1999).
8. Chosidow O, Chastang C, Brue A et al. Controlled study of malathion and D-phenothrin lotions for Pediculus humanus var capitis-infested schoolchildren. Lancet 344, 1724-1727 (1994).
9. Mumcuoglu KY, Hemingway J, Miller J et al. Permethrin resistance in the head louse Pediculus capitis from Israel. Med. Vet. Entomol. 9, 427-432 (1995).
10. Downs AMR, Stafford KA, Harvey I, Coles GC. Evidence for double resistance to permethrin and malathion in head lice. Br. J. Dermatol. 141, 508-511 (1999).
11. Meinking TM, Clineschmidt CM, Chen C et al. An observer-blinded study of 1% permethrin crème rinse with and without adjunctive combing in patients with head lice. J. Pediatrics 141, 665-670 (2002).
12. Burkhart CG, Burkhart CN. Clinical evidence of lice resistance to over-the-counter products. J. Cut. Med. Surg. 4, 199-201 (2000).
13. Meinking TL, Burkhart CG, Burkhart CN. Ectoparasitic diseases in dermatology: Reassessment of scabies and pediculosis. Adv. Dermatol. 15, 67-108 (1999).
14. Frankowski BL. American Academy of Pediatrics guidelines for the prevention and treatment of head lice infestation. Am. J. Manag. Care 10, 269-272 (2004).
15. Burkhart CG, Burkhart CN. Oral ivermectin for Phthirus pubis. J. Am. Acad. Dermatol. 51, 1037 (2004).
16. Dodd CS. Interventions for treating headlice. Update of Cochrane Database Syst Rev. 2001;(3):CD001165. Cochrane Database Syst. Rev. 18, CD001165 (2007).
17. Falagas ME, Matthaiou DK, Rafailidis PI, Panos G, Pappas G. Worldwide prevalence of head lice. Emerg. Infect. Dis. 14, 1493-1494 (2008).
18. Mumcuoglu KY, Miller J, Gofin R et al. Head lice in Israeli children: parents' answers to an epidemiological questionnaire. Public Health Rev. 18, 333-344 (1990/1991).
19. Willems S, Lapeere H, Haedens N, Pasteels I, Naeyaert JM, De Maeseneer J. The importance of socio-economic status and individual characteristics on the revalence of head lice in schoolchildren. Eur. J. Dermatol. 15, 387-392 (2005).
20. Mumcuoglu KY, Friger M, Ioffe-Uspensky I, Ben-Ishai F, Miller J. Louse comb versus direct visual examination for the diagnosis of head louse infestations. Pediatric Dermatol. 18, 9-12 (2001).
21. Alkinson I, Clore ER, Kisel BE, Posch I. Internal and external parasites. Pediatrics 1, 1-7 (1986).
22. Mumcuoglu KY. Prevention and treatment of head lice in children. Paediatr. Drugs 1, 211-218 (1999).
23. Speare R, Buettner PG. Head lice in pupils of a primary school in Australia and implications for control. Int. J. Dermatol. 38, 285-290 (1999).
24. Williams LK, Reichert A, MacKenzie WR, Hightower AW, Blake PA. Lice, nits, and school policy. Pediatrics 107, 1011-1015 (2001).
25. Balcioglu C, Burgess IF, Limoncu ME et al. Plastic detection comb better than visual screening for diagnosis of head louse infestation. Epidemiol. Infect. 136, 1425-1431 (2008).
26. De Maeseneer J, Blokland I, Willems S, Vander Stichele R, Meersschaut F. Wet combing versus traditional scalp inspection to detect head lice in schoolchildren: observational study. BMJ 321 (7270), 1187-1188 (2000).
27. Mumcuoglu KY, Miller J, Gofin R et al. Epidemiological studies on head lice infestation in Israel. I. Parasitological examination of children. Int. J. Dermatol. 29, 502-506 (1990).
28. Buxton PA. The Louse: an Account on the Lice Which Infest Man, Their Medical Importance and Control. Arnold, London, UK (1950).
29. Milne LC, Greenway P. Color in children's drawings: the influence of age and gender. Arts Psychother. 26, 261-263 (1999).
30. Mumcuoglu KY. Head lice in drawings of kindergarten children. Israel J. Psychiatry Rel. Sci. 28, 25-32 (1991).
31. Meinking TL, Taplin D. Infestations. In: Pediatric Dermatology (3rd Edition). Schachner LA, Hansen RC (Eds). Mosby, NY, USA 1141-1180 (2003).
32. Mumcuoglu KY. Control of head louse (Anoplura: Pediculidae) infestations: past and present. Am. Entomol. 42, 175-178 (1996).
33. Mumcuoglu KY. Effective treatment of head louse with pediculicides. J. Drugs Dermatol. 5, 451-452 (2006).
34. Hemingway J, Miller J, Mumcuoglu KY. Pyrethroid resistance mechanisms in the head louse Pediculus humanus capitis from Israel: implications for control. Med. Vet. Entomol. 13, 89-96 (1999).
35. Mumcuoglu KY, Barker SC, Burgess IF et al. International guidelines for effective control of head louse infestations. J. Drugs Dermatol. 6, 409-414 (2007).
36. Kwon DH, Yoon KS, Strycharz JP, Clark JM, Lee SH. Determination of permethrin resistance allele frequency of human head louse populations by quantitative sequencing. J. Med. Entomol. 45, 912-920 (2008).
37. Durand R, Millard B, Bouges-Michel C, Bruel C, Bouvresse S, Izri A. Detection of pyrethroid resistance gene in head lice in schoolchildren from Bobigny, France. J. Med. Entomol. 44, 796-798 (2007).
38. Thomas DR, McCarroll L, Roberts R et al. Surveillance of insecticide resistance in head lice using biochemical and molecular methods. Arch. Dis. Child. 91, 777-778 (2006).
39. Kristensen M, Knorr M, Rasmussen AM, Jespersen JB. Survey of permethrin and malathion resistance in human head lice populations from Denmark. J. Med. Entomol. 43, 533-538 (2006).
40. González Audino P, Barrios S, Vassena C, Mougabure Cueto G, Zerba E, Picollo MI. Increased monooxygenase activity associated with resistance to permethrin in Pediculus humanus capitis (Anoplura: Pediculidae) from Argentina. J. Med. Entomol. 42, 342-345 (2005).
41. Kasai S, Ishii N, Natsuaki M et al. Prevalence of kdr-like mutations associated with pyrethroid resistance in human head louse populations in Japan. J. Med. Entomol. 46, 77-82 (2009).
42. Strycharz JP, Yoon KS, Clark JM. A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae). J. Med. Entomol. 45, 75-81 (2008).
43. Badiaga S, Raoult D, Brouqui P. Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerg. Infect. Dis. 14, 1353-1359 (2008).
44. Foucault C, Ranque S, Badiaga S, Rovery C, Raoult D, Brouqui P. Oral ivermectin in the treatment of body lice. J. Infect. Dis. 193, 474-476 (2006).
45. Chosidow O. Scabies and pediculosis. Lancet 355 (9206), 819-826 (2000).
46. Burkhart CN, Burkhart CG. Another look at Ivermectin in the treatment of scabies and head lice. Int. J. Dermatol. 38, 235 (1999).
47. Vander Stichele RH, Dezeure EM, Bogaert MG. Systematic review of clinical efficacy of topical treatments for head lice. BMJ 311, 604-608 (1995).
48. Mumcuoglu KY, Miller J, Zamir C, Zentner G, Helbin H, Ingber A. The in vivo pediculicidal efficacy of a natural remedy. Isr. Med. Assoc. J. 4, 790-793 (2002).
49. Heukelbach J, Canyon DV, Oliveira FA, Muller R, Speare R. In vitro efficacy of over-the-counter botanical pediculicides against the head louse Pediculus humanus var capitis based on a stringent standard for mortality assessment. Med. Vet. Entomol. 22, 264-272 (2008).
50. Toloza AC, Vassena C, Picollo MI. Ovicidal and adulticidal effects of monoterpenoids against permethrin-resistant human head lice, Pediculus humanus capitis. Med. Vet. Entomol. 22, 335-339 (2008).
51. Gonzalez Audino P, Vassena C, Zerba E, Picollo M. Effectiveness of lotions based on essential oils from aromatic plants against permethrin resistant Pediculus humanus capitis. Arch. Dermatol. Res. 299, 389-392 (2007).
52. Carpinella MC, Miranda M, Almirón WR, Ferrayoli CG, Almeida FL, Palacios SM. In vitro pediculicidal and ovicidal activity of an extract and oil from fruits of Melia azedarach L. J. Am. Acad. Dermatol. 56, 250-256 (2007).
53. Abdel-Ghaffar F, Semmler M. Efficacy of neem seed extract shampoo on head lice of naturally infected humans in Egypt. Parasitol. Res. 100, 329-332 (2007).
54. Priestley CM, Burgess IF, Williamson EM. Lethality of essential oil constituents towards the human louse, Pediculus humanus, and its eggs. Fitoterapia 77, 303-309 (2006).
55. Yang YC, Lee HS, Lee SH, Clark JM, Ahn YJ. Ovicidal and adulticidal activities of Cinnamomum zeylanicum bark essential oil compounds and related compounds against Pediculus humanus capitis (Anoplura: Pediculicidae). Int. J. Parasitol. 35, 1595-1600 (2005).
56. Canyon DV, Speare R. A comparison of botanical and synthetic substances commonly used to prevent head lice (Pediculus humanus var. capitis) infestation. Int. J. Dermatol. 46, 422-426 (2007).
57. Ibarra J, Fry F, Clarice W et al. Overcoming health inequalities by using the Bug Busting 'whole-school approach' to eradicate head lice. J. Clin. Nurs. 16, 1955-1965 (2007).
58. Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. Lancet 356, 540-544 (2000).
59. Bingham P, Kirk S, Hill N, Figueroa J. The methodology and operation of a pilot randomized control trial of the effectiveness of the Bug Busting method against a single application insecticide product for head louse treatment. Public Health 114, 265-268 (2000).
60. Plastow L, Luthra M, Powell R et al. Lice infestation: bug busting vs. traditional treatment. J. Clin. Nurs. 10, 775-783 (2001).
61. Hill N, Moor G, Cameron MM et al. Single blind, randomised, comparative study of the Bug Buster kit and over the counter pediculicide treatments against head lice in the United Kingdom. BMJ 331, 384-387 (2005).
62. Goates BM, Atkin JS, Wilding KG et al. An effective nonchemical treatment for head lice: a lot of hot air. Pediatrics 118, 1962-1970 (2006).
63. Burgess IF. The mode of action of dimeticone 4% lotion against head lice, Pediculus capitis. BMC Pharmacol. 9, 3 (2009).
64. Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ 330 (7505), 1423 (2005).
65. Burgess IF, Lee PN, Matlock G. Randomised, controlled, assessor blind trial comparing 4% dimeticone lotion with 0.5% malathion liquid for head louse infestation. PLoS ONE 2, e1127 (2007).
66. Oliveira FA, Speare R, Heukelbach J. High in vitro efficacy of Nyda L, a pediculicide containing dimeticone. J. Eur. Acad. Dermatol. Venereol. 21, 1325-1329 (2007).
67. Kaul N, Palma KG, Silagy SS, Goodman JJ, Toole J. North American efficacy and safety of a novel pediculicide rinse, isopropyl myristate 50% (Resultz). J. Cutan. Med. Surg. 11, 161-167 (2007).
68. Mumcuoglu KY, Galun R, Bach U, Miller J, Magdassi S. Repellency of essential oils and their components to the human body louse, Pediculus humanus humanus. Entomol. Exp. Appl. 78, 309-314 (1996).
69. Mumcuoglu KY, Magdassi S, Miller J et al. The in vivo repellency of a citronella formulation for the human head louse, Pediculus humanus capitis. Israel Med. Assoc. J. 6, 756-759 (2004).
70. Takano-Lee M, Edman JD, Mullens BA, Clark JM. Transmission potential of the human head louse, Pediculus capitis (Anoplura: Pediculidae). Int. J. Dermatol. 44, 811-816 (2005).
71. Burkhart CN, Burkhart CG. Fomite transmission in head lice. J. Am. Acad. Dermatol. 56, 1044-1047 (2007).
72. Lang JD. Biology and Control of the Head Louse, Pediculus humanus capitis (Anoplura: Pediculidae) in a Semi-arid Urban Area. PhD thesis. University of Arizona Press, Tucson, AZ, USA (1975).
73. Izri A, Chosidow O. Efficacy of machine laundering to eradicate head lice: recommendations to decontaminate washable clothes, linens, and fomites. Clin. Infect. Dis. 42, 9-10 (2006).
74. Burkhart CN, Burkhart CG. Head lice: scientific assessment of the nit sheath with clinical ramifications and therapeutic options. J. Am. Acad. Dermatol. 53, 129-133 (2005).
75. Pollack RJ, Kiszewski A, Spielman A. Overdiagnosis and consequent mismanagement of head louse infestations in North America. Pediatric Inf. Dis. J. 19, 689-693 (2000).
76. Williams LK, Richert A, MacKenzie WR, Hightower AW, Blake PA. Lice, nits, and school policy. Pediatrics, 107, 1011-1015 (2001).
77. Frankowski BL, Weiner LB. Head lice. Pediatrics 110, 638-643 (2002).
78. Dolianitis C, Sinclair R. Optimal treatment of head lice: is a no-nit policy justified? Clin. Dermatol. 20, 94-96 (2002).
79. Mumcuoglu KY, Meinking T, Burkhart CN, Burkhart CG. Head louse infestation: the "no-nit" policy and its consequences. Int. J. Dermatol. 45, 891-896 (2006).
80. Sciscione P, Krause-Parello CA. No-nit policies in schools: time for change. J. Sch. Nurs. 23, 13-20 (2007).
81. Reed DL, Smith VS, Hammond SL, Rogers AR, Clayton DH. Genetic analysis of lice supports direct contact between modern and archaic humans. PLoS Biol. 2, 340 (2004).
82. Reed DL, Light JE, Allen JM, Kirchman JJ. Pair of lice lost or parasites regained: the evolutionary history of anthropoid primate lice. BMC Biol. 5, 7 (2007).
83. Light JE, Toups MA, Reed DL. What's in a name: the taxonomic status of human head and body lice. Mol. Phylogenet. Evol. 47(3), 1203-1206 (2008).
84. Light JE, Allen JM, Long LM et al. Geographic distributions and origins of human head lice (Pediculus humanus capitis) based on mitochondrial data. J. Parasitol. 94, 1275-1281 (2008).
85. Leo NP, Hughes JM, Yang X, Poudel SK, Brogdon WG, Barker SC. The head and body lice of humans are genetically distinct (Insecta: Phthiraptera, Pediculidae): evidence from double infestations. Heredity 95, 34-40 (2005).
86. Mumcuoglu KY. Human lice: Pediculus and Pthirus. In: Paleomicrobiology - Past Human Infections. Raoult D, Drancourt M (Eds). Springer, Berlin, Germany 215-222 (2008).
87. Raoult D, Dutour O, Houhamdi L et al. Evidence for louse-transmitted diseases in soldiers of Napoleon's Grand Army in Vilnius. J. Infect. Dis. 193, 112-120 (2006).
88. Raoult D, Reed DL, Dittmar K et al. Molecular identification of lice from pre-Columbian mummies. J. Infect. Dis. 197, 535-543 (2008).
89. Badiaga S, Raoult D, Brouqui P. Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerg. Infect. Dis. 14(9), 1353-1359 (2008).
90. Nutanson I, Steen CJ, Schwartz RA, Janniger CK. Pediculus humanus capitis: an update. Acta Dermatovenerol. Alp. Panonica Adriat. 17, 147-154, 156-157, 159 (2008).
91. Mikhail M, Weinberg JM, Smith BL. What's eating you? Body lice (Pediculus humanus var corporis). Cutis 80, 397-398 (2007).
92. Houhamdi L, Parola P, Raoult D. Lice and lice-borne diseases in humans (in French). Med. Trop. 65, 13-23 (2005).
93. Bechah Y, Capo C, Mege JL, Raoult D. Epidemic typhus. Lancet Infect. Dis. 8, 417-426 (2008).
94. Nutanson I, Steen C, Schwartz RA. Pediculosis corporis: an ancient itch. Acta Dermatovenerol. Croat. 15, 33-38 (2007).
95. Galiczynski EM Jr, Elston DM. What's eating you? Pubic lice (Pthirus pubis). Cutis 81, 109-114 (2008).
96. Varela JA, Otero L, Espinosa E, Sánchez C, Junquera ML, Vázquez F. Phthirus pubis in a sexually transmitted diseases unit: a study of 14 years. Sex. Transm. Dis. 30, 292-296 (2003).
97. Chuh A, Lee A, Wong W, Ooi C, Zawar V. Diagnosis of Pediculosis pubis: a novel application of digital epiluminescence dermatoscopy. J. Eur. Acad. Dermatol. Venereol. 21, 837-838 (2007).
98. Burkhart CG, Burkhart CN. Top 10 head lice concerns. Skinmed 5, 269-270 (2006).
99. Ayoub N, Merhy M, Tomb R. Treatment of pubic phthiriasis with oral albendazole (in French). Ann. Dermatol. Venereol. 135, 602-603 (2008).
100. Ko CJ, Elston DM. Pediculosis. J. Am. Acad. Dermatol. 50, 1-12 (2004).
101. Kaul N, Palma KG, Silagy SS, Goodman JJ, Toole J. North American efficacy and safety of a novel pediculicide rinse, isopropyl myristate 50% (Results). J. Cutan. Med. Surg. 11, 161-167 (2007).
102. Manjunatha NP, Jayamanne GR, Desai SP, Moss TR, Lalik J, Woodland A. Pediculosis pubis: presentation to ophthalmologist as pthriasis palpebrarum associated with corneal epithelial keratitis. Int. J. STD AIDS 7, 424-426 (2006).
103. Pinckney J 2nd, Cole P, Vadapalli SP, Rosen T. Phthiriasis palpebrarum: a common culprit with uncommon presentation. Dermatol. Online J. 14, 7 (2008).
104. Gillis D, Slepon R, Karsenty E, Green MS. Sociodemographic factors associated with Pediculosis capitis and pubis among young adults in the Israel Defense Forces. Public Health Rev. 18, 345-350 (1990-1991).
105. Mimouni D, Grotto I, Haviv J, Gdalevich M, Huerta M, Shpilberg O. Secular trends in the epidemiology of pediculosis capitis and pubis among Israeli soldiers: a 27-year follow-up. Int. J. Dermatol. 40(10), 637-639 (2001).
106. Mimouni D, Ankol OE, Gdalevich M, Grotto I, Davidovitch N, Zangvil E. Seasonality trends of Pediculosis capitis and Phthirus pubis in a young adult population: follow-up of 20 years. J. Eur. Acad. Dermatol. Venereol. 16(3), 257-259 (2002).
107. Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin. Microbiol. Rev. 20, 268-279 (2007).
108. Tjioe M, Vissers WH. Scabies outbreaks in nursing homes for the elderly: recognition, treatment options and control of reinfestation. Drugs Aging 25, 299-306 (2008).
109. Walton SF, Beroukas D, Roberts-Thomson P, Currie BJ. New insights into disease pathogenesis in crusted (Norwegian) scabies: the skin immune response in crusted scabies. Br. J. Dermatol. 158, 1247-1255 (2008).
110. Dupuy A, Dehen L, Bourrat E et al. Accuracy of standard dermoscopy for diagnosing scabies. J. Am. Acad. Dermatol. 59, 530 (2008).
111. Ahlgrimm-Siess V, Koller S, El Shabrawi-Caelen L, Hofmann-Wellenhof R, Kerl H. New diagnostic methods in dermatopathology: in vivo reflectance confocal microscopy. J. Dtsch Dermatol. Ges. 6, 591-592 (2008).
112. Alexander JO'D. Arhtropods and Human Skin. Springer-Verlag, Berlin, Germany 227-292 (1984).
113. Chosidow O. Clinical practices. Scabies. N. Engl. J. Med. 354, 1718-1727 (2006).
114. Ishii N, Asahina A, Amagai M et al. Guideline for the diagnosis and treatment of scabies in Japan (second edition). J. Dermatol. 35, 378-393 (2008).
115. Leone PA. Scabies and pediculosis pubis: an update of treatment regimens and eneral review. Clin. Infect. Dis. 44(Suppl. 3), 153-159 (2007).
116. Balfanz U. Antipruriginosum auch bei Skabies effektiv. Artz Praxis 30, 245-247 (1978).
117. Cubela V, Yawalker SJ. Clinical experience with crotamiton cream and lotion in treatment of infants with scabies. Br. J. Clin. Pract. 32, 229-231 (1978).
118. Konstantinov D, Stanoeva I, Yawalkar SJ. Crotamiton cream and lotion in treatment of infants and young children with scabies. J. Int. Med. Res. 7, 443-448 (1979).
119. Hurwitz S. Scabies in infants and children. In: Scabies and Pediculosis. Orkin M, Maibach HI, Parish LC, Schwartzman RM (Eds). Lippincott, PA, USA 31-38 (1977).
120. Wooldridge W. The gamma isomer of hexachlorocyclohexane in treatment of scabies. J. Invest. Dermatol. 10, 363-366 (1948).
121. Cannon AB, McRae ME. Treatment of scabies; report of one hundred patients treated with hexachlorocyclohexane in vanishing cream base. JAMA 138, 557 (1948).
122. Schultz MW, Gomez M, Hansen RC et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch. Dermatol. 126, 167-170 (1990).
123. Amer M, El-Bayoumi M, Rizk MK. Treatment of scabies; preliminary report. Int. J. Dermatol. 20, 289-290 (1981).
124. Hans R. Aplastic anaemia associated with gamma benzene hexachloride. JAMA 236, 1009-1010 (1976).
125. Lee B. Groth P. Scabies - transcutaneous poisoning during treatment. Paediatrics 59, 643 (1977).
126. Rasmussen JE. The problem of lindane. J. Am. Acad. Dermatol. 5, 507-516 (1981).
127. Maibach HI, Orkin M. Adverse reactions to treatment. In: Scabies and Pediculosis. Orkin M, Maibach HI, Parish LC, Schwartzman RM (Eds). Lippincott, PA, USA 17-124 (1977).
128. Pramanik AK, Hansen RC. Transcutaneous gamma benzenhexachloride absorption and toxicity in infants and children. Arch. Dermatol. 115, 1224-1225 (1979).
129. Solomon LM, Fahrner L, West DP. Gamma benzene hexachloride toxicity. Arch. Dermatol. 113, 353-357 (1977).
130. Purvis RS, Tyring SK. An outbreak of lindane-resistant scabies treated successfully with permethrin 5% cream. J. Am. Acad. Dermatol. 25, 1015-1016 (1991).
131. Meinking T, Taplin D, Hermida J, Pardo R, Kerdel F. The treatment of scabies with ivermectin. N. Engl. J. Med. 333, 26-30 (1995).
132. del Giudice P, Chosidow O, Caumes E. Ivermectin in dermatology. J. Drugs Dermatol. 2, 13-21 (2003).
133. Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst. Rev. 2, CD000320 (2007).
134. Paller AS. Scabies in infants and small children. Semin. Dermatol. 12, 3-8 (1993).
135. Brown S, Becher J, Brady W. Treatment of ectoparasitic infections: review of the English-language literature, 1982-1992. Clin. Infect. Dis. 20, 104-109 (1995).
136. Usha V, Gopalakrishnan-Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J. Am. Acad. Dermatol. 42, 236-240 (2000).
137. Buffet M, Dupin N. Current treatments for scabies. Fundam. Clin. Pharmacol. 17, 217-225 (2003).
138. Scheinfeld N. Controlling scabies in institutional settings: a review of medications, treatment models, and implementation. Am. J. Clin. Dermatol. 5, 31-37 (2004).
139. Pasay C, Arlian L, Morgan M et al. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med. Vet. Entomol. 22, 82-88 (2008).
140. Pasay C, Walton S, Fischer K, Holt D, McCarthy J. PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var. hominis). Am. J. Trop. Med. Hyg. 74, 649-657 (2006).
141. Mounsey KE, Holt DC, McCarthy J, Currie BJ, Walton SF. Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol. 3, 57-66 (2008).
142. Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin. Infect. Dis. 39, e8-e12 (2004).
143. Burkhart CG. Recent immunologic considerations regarding the itch and treatment of scabies. Dermatol. Online J. 12, 7 (2006).